Phase I study of sunitinib (SU) in combination with pemetrexed (Pem) in patients (pts) with advanced solid tumors (ST)

被引：0
|
作者：
Nakagawa, K. [1 ,2 ]
Okamoto, I. [1 ,2 ]
Shimizu, T. [1 ,2 ]
Miyazaki, M. [1 ,2 ]
Tsurutani, J. [1 ,2 ]
Ichikawa, Y. [1 ,2 ]
Terashima, M. [1 ,2 ]
Takeda, M. [1 ,2 ]
Fumita, S. [1 ,2 ]
Kiriyama, T. [1 ,2 ]
机构：
[1] Kinki Univ, Sch Med, Osaka 589, Japan
[2] Pfizer Japan Inc, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14630
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PHASE I, DOSE-FINDING STUDY OF SUNITINIB (SU) IN COMBINATION WITH IRINOTECAN (IR) IN PATIENTS WITH ADVANCED SOLID TUMOURS
    Boven, E.
    Massard, C.
    Armand, J. P.
    Tillier, C.
    Hartog, V.
    Brega, N. M.
    Contouriotis, A. M.
    Law, C. N. J.
    Soria, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 156 - 157
  • [32] A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with docetaxel in patients with advanced solid tumors
    Robert, F.
    Sandler, A.
    Schiller, J. H.
    Ilagan, J.
    Harper, K.
    Vermeulen, W.
    Liu, G.
    Tye, L.
    Chao, R.
    Verkh, L.
    Traynor, A.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3514S - 3515S
  • [33] Phase I study of pemetrexed (P) plus gemcitabine (G) in advanced solid tumors (ST)
    Fury, M. G.
    Larkin, J.
    Gerst, S. R.
    Sabbatini, P.
    Konner, J.
    Orlando, M.
    Tai, D. F.
    Goss, T.
    Aghajanian, C.
    Hensley, M. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] Sunitinib combined with pemetrexed and cisplatin in patients with advanced solid malignancies: phase I dose escalation study
    Blais, N.
    Camidge, D. R.
    Jonker, D. J.
    Soulieres, D.
    Doebele, R. C.
    Ruiz-Garcia, A.
    Thall, A.
    Chao, R.
    Eckhardt, S. G.
    Chow, L. Q.
    EJC SUPPLEMENTS, 2009, 7 (02): : 552 - 552
  • [35] Expanded phase I study of vorinostat (VOR) in combination with capecitabine (CAP) in patients (pts) with advanced solid tumors
    Townsley, C.
    Oza, A. M.
    Tang, P.
    Siu, L. L.
    Pond, G. R.
    Sarveswaran, P.
    Webster, S.
    Zwiebel, J. A.
    Chen, E. X.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] A phase I study of MK-2206 in combination with lapatinib in patients (pts) with advanced solid tumors.
    Wisinski, Kari Braun
    Tevaarwerk, Amye
    Bell, Maria
    Burkard, Mark E.
    Eickhoff, Jens C.
    Wilding, George
    LoConte, Noelle K.
    Traynor, Anne M.
    Hoang, Tien
    Heideman, Jennifer
    Kolesar, Jill
    Liu, Glenn
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] Phase I study of PM00104 in combination with carboplatin (C) in patients (pts) with advanced solid tumors
    Calvo, E.
    Gil, M.
    Coronado, C.
    Valer, A.
    Duran, I.
    Hidalgo, M.
    Pardo, B.
    Calles, A.
    Garcia, M.
    Morelli, P.
    Kahatt, C. M.
    Prados, R.
    Fernandez, C.
    Salazar, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [38] A phase II study of pemetrexed in patients (pts) with advanced neuroendocrine tumors (NETs)
    Bhargava, P.
    Earle, C. C.
    Zhu, A. X.
    Clark, J. W.
    Vincitore, M.
    Battu, S.
    Regan, E.
    Lawrence, C.
    Kulke, M. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [39] Phase I study of pemetrexed and sorafenib in advanced solid tumors.
    Poklepovic, Andrew Stewart
    Shafer, Danielle A.
    Roberts, John D.
    Geyer, Charles E.
    Dent, Paul
    Moran, Richard
    Tombes, Mary Beth
    Shrader, Ellen
    Strickler, Kathryn
    Wan, Wen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors
    Joanna M. Brell
    Smitha S. Krishnamurthi
    Linda Rath
    Joseph A. Bokar
    Panayiotis Savvides
    Joseph Gibbons
    Matthew M. Cooney
    Neal J. Meropol
    Percy Ivy
    Afshin Dowlati
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 547 - 553
12345